REMUS Remus Pharmaceuticals Ltd Management Changes Announcement 2026 - Internal Auditor Appointment Remus Pharmaceuticals appoints Sharp & Tannan Associates as Internal Auditor for FY 2026-27, under SEBI Listing Regulations, effective May 20, 2026..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Remus Pharmaceuticals Ltd